指南与共识儿科与产科急症消化、代谢与肾脏急症

减少与COVID-19相关的污名和歧视:早期大流行快速综述与实践建议

Reducing stigma and discrimination associated with COVID-19: early stage pandemic rapid review and practical recommendations.
指南 / 共识 · Epidemiol Psychiatr Sci · 2021-01-28
一句话结论基于WHO方法快速综述证据,提出减少COVID-19相关污名与歧视的语言、媒体、公共卫生干预及社区参与等推荐,供决策者纳入疫情应对。

该快速综述采用世界卫生组织(WHO)突发卫生事件临时指南制定方法,检索PubMed/MEDLINE、PsycINFO、Cochrane Central和Campbell Collaboration至2020年4月中旬,补充参考文献检索和专家推荐,纳入12篇系统综述和29篇补充文章。综述围绕COVID-19相关语言用词、媒体/新闻实践、公共卫生干预、针对关键群体的靶向公共卫生干预以及社区和关键利益相关方参与五个方面制定推荐。作者结论认为这些推荐是首份关于减少COVID-19污名和歧视的综合循证指南,减少污名有助于减轻痛苦和负面体验、增强社区在特殊时期合作决心,并有助于解决驱动边缘化和加剧健康风险的结构性不平等。作者敦促行政管理和决策者考虑将这些推荐整合到持续的COVID-19应对中。

要点

  • 推荐围绕五个方面:COVID-19及相关人群的语言用词、媒体/新闻实践、公共卫生干预、针对关键群体的靶向公共卫生干预、社区和关键利益相关方参与。
  • 综述采用WHO突发卫生事件临时指南制定方法和WHO「证据到决策」框架制定减少COVID-19污名的策略推荐。
  • 检索至2020年4月中旬,共识别4150条可能相关记录,最终纳入12篇系统综述和29篇补充文章。
  • 作者认为减少污名有助于减轻痛苦和负面体验、增强社区在特殊时期合作决心,并有助于解决驱动边缘化和加剧健康风险的结构性不平等。
  • 作者敦促行政管理和决策者考虑将这些推荐整合到持续的COVID-19应对中。

适用人群与场景

  • 涉及COVID-19或受COVID-19影响的人群,以及减少与COVID-19相关的污名和歧视所针对的关键群体和社区。

处置流程与药物剂量

  • 推荐关注与COVID-19及相关人群交流时使用的语言和用词。
  • 推荐关注媒体和新闻实践。
  • 推荐关注公共卫生干预。
  • 推荐关注针对关键群体的靶向公共卫生干预。
  • 推荐关注社区和关键利益相关方的参与。

研究设计与关键结果

  • 研究类型为快速综述,采用WHO突发卫生事件临时指南制定方法,检索PubMed/MEDLINE、PsycINFO、Cochrane Central和Campbell Collaboration至2020年4月中旬,并补充参考文献检索和专家推荐。
  • 共识别4150条可能相关记录,纳入12篇系统综述和29篇补充文章。
  • 推荐聚焦五个方面:COVID-19及相关人群的语言/用词、媒体/新闻实践、公共卫生干预、针对关键群体的靶向公共卫生干预、社区和关键利益相关方参与。
  • 作者结论认为这些推荐是首份关于减少COVID-19污名和歧视的综合循证指南。

证据类型、等级与局限

  • 证据类型为快速综述,采用WHO突发卫生事件临时指南制定方法和WHO「证据到决策」框架,综述方案在PROSPERO注册(注册号CRD42020177677)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为减少污名有助于减轻痛苦和负面体验、增强社区在特殊时期合作决心,并有助于解决驱动边缘化和加剧健康风险的结构性不平等。
  • 作者敦促行政管理和决策者考虑将这些推荐整合到持续的COVID-19应对中。

指南或共识出处

  • 世界卫生组织(WHO)突发卫生事件临时指南制定方法;WHO「证据到决策」框架。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIMS: To develop recommendations for strategies and interventions to reduce stigma and discrimination related to coronavirus disease 2019 (COVID-19), through reviewing and synthesising evidence in relation to COVID-19 and other disease outbreaks and infectious/stigmatised conditions from systematic reviews and primary studies and recommendations from additional materials.

METHODS: Rapid review, drawing on the World Health Organization's (WHO) methodology for developing interim guidelines during health emergencies. PubMed/MEDLINE, PsycINFO, Cochrane Central and Campbell Collaboration searched up to mid-April 2020. Searches were supplemented by reference-searching and expert recommendations. Searches were designed to identify: (1) systematic reviews (<10 years), or (2) primary intervention studies (no date limit) reporting evidence on anti-stigma interventions (in relation to COVID-19 or other infectious/stigmatised conditions) or (3) additional relevant materials. Data were extracted on population, intervention, outcome and results. These data were compiled into evidence summary tables and narrative overviews. Recommendations on strategies for COVID-19 stigma-reduction were developed using the WHO 'Evidence to Decision' framework approach. The review protocol was registered with PROSPERO (registration ID: CRD42020177677).

RESULTS: The searches identified a total of 4150 potentially relevant records, from which 12 systematic reviews and 29 additional articles were included. Overarching considerations and specific recommendations focus on: (1) language/words used in relation to COVID-19 and affected people; (2) media/journalistic practices; (3) public health interventions; (4) targeted public health interventions for key groups and (5) involving communities and key stakeholders.

CONCLUSIONS: These recommendations represent the first consolidated evidence-based guidance on stigma and discrimination reduction in relation to COVID-19. Mitigating the impact of stigma is critical in reducing distress and negative experiences, and strengthening communities' resolve to work together during exceptional circumstances. Ultimately, reducing stigma helps addressing structural inequalities that drive marginalisation and exacerbate both health risks and the impact of stigma. Administrations and decision makers are urged to consider integrating these recommendations into the ongoing COVID-19 response.

来源:Epidemiol Psychiatr Sci,查看原文。版权归原作者所有。

参考来源

  1. Gronholm PC, Nosé M, van Brakel WH, et al. Reducing stigma and discrimination associated with COVID-19: early stage pandemic rapid review and practical recommendations. Epidemiol Psychiatr Sci. 2021. PMID: 33504412. doi:10.1017/S2045796021000056

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。